About Adam Lemon
Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked within financial markets over a 12-year period, including 6 years with Merrill Lynch.
Chief Analyst for DailyForex since October 2013
Education:
B.A. in Political Science from the University of Warwick, U.K.
Diplomas in Law and Legal Practice from the College of Law, London, U.K.
Financial Qualifications:
Fund Management, Investment Management – U.K. Chartered Institute for Securities & Investment
Financial Career Highlights:
AVP, Merrill Lynch International Bank,U.K.
Featured In:
FXStreet,Gold-Eagle , MoneyShow
Favorite assets to trade: anything trending strongly or with high volatility
Latest 12 Articles
Invest in nuclear energy stocks like Centrus Energy and PEG for exposure to SMRs, uranium, and clean energy growth opportunities.
Invest in gold stocks for portfolio diversification. Top picks include SSR Mining, Agnico Eagle, and Caledonia Mining amid high gold prices.
Stock markets and the US Dollar lost ground last week against a backdrop of increasing market nervousness, and an increasing belief that the Fed will not make a rate cut in December.
Top Forex Brokers
The Australian Dollar has started to gain more strongly as risk sentiment improves more firmly after the US government shutdown is ended.
An overreaction to an earnings miss, a warning on the economy, and strong operational metrics converge. Should you load up on Chipotle Mexican Grill shares?
A solid earnings release, increased guidance, robust free cash flow, and a strong order pipeline drive bullish factors. Is there more upside for Leidos Holdings after strong earnings data?
An improved outlook, a year-over-year decline in earnings per share, contracting margins, and rising medical costs create an engaging narrative for UnitedHealth Group. Should you buy the sell-off?
US Government Shutdown Ends, But CPI Data Unlikely to be Released; US and European Stock Markets Advance; December Fed Rate Cut Chance Nears 50-50; Precious Metals Higher, Silver Nears Record; USD/JPY Breaks ¥155; Crude Oil Falls on Glut; UK GDP Contracts
Slow net income growth, negative sentiment across the real estate sector, and an unsustainable dividend yield could spell trouble ahead. Did earnings confirm more downside for Invitation Homes?
Bonuses & Promotions
An earnings miss, a disappointing return on equity, and a decrease in the top-end full-year EPS guidance raised red flags. Did earnings suggest downside ahead for Evergy?
Excellent profit margins, understated future earnings potential, and winning the bidding war for Metsera have injected bullishness. Should you buy Pfizer following the Metsera deal?
Improving risk sentiment is boosting the Euro, but it is also holding up the Dollar, so gains here might be limited.